☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ARS Pharmaceuticals
ARS Pharmaceuticals Reports the EC’s Approval of Eurneffy (Adrenaline Nasal Spray) to Treat Type I Allergic Reactions
August 26, 2024
ARS Pharmaceuticals’ neffy (Epinephrine Nasal Spray) Gains the US FDA’s Approval to Treat Type I Allergic Reactions
August 12, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.